AI-Driven Biomarkers for Antibody-Drug Conjugates (ADC)

In this episode, I discuss with Dr. Salgado, Co-Chair of the International Immuno-Oncology Biomarkers Working Group, his editorial (https://doi.org/10.1016/j.ccell.2025.03.020) on the recent Cancer Cell study by Ding Ma et al, presenting a predictive AI model for HER2-targeting ADC efficacy, incorporating immune system components, hormone receptor status, clinical staging, and HER2+ cell proportion.

#ImmunoOncology

#HER2Biomarker

#AntibodyDrugConjugates